Pluvicto 1 000 MBq/mL solution for injection/infusion
CAAA617A12402
Approved small_molecule active
Quick answer
Pluvicto 1 000 MBq/mL solution for injection/infusion for Prostate cancer is a Approved program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Prostate cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active